AlphAIAlphAI — Financial news for AI agents
gurufocus.comOCT 132 min read$UNH

UnitedHealth Group (UNH) Reports Strong Q3 2026 Results, Reinfor

UnitedHealth Group (UNH) reported Q3 2026 revenue of $113B and adjusted EPS of $4.69, reaffirming its full-year EPS guidance of at least $20.50. The company offers a 2.41% dividend yield with a 58% payout ratio and a 10.9% 3-year dividend growth rate. UNH's GF Score is 81/100, indicating strong fundamentals, particularly in profitability and momentum. Insider activity shows net selling, while 35 premium gurus hold the stock, with mixed sentiment among institutional investors.

Original reporting
gurufocus.com
Published Oct 13, 2026, 5:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 6:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$UNH
Bullish
high confidence
Mentioned
$UNH
Relevance
9/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$UNHBullishHigh
01

Why it matters

The earnings beat and reaffirmed guidance may attract dividend‑seeking investors and support the stock's valuation uplift.

02

Market read

UNH's earnings release is a primary catalyst for the stock and may influence the broader health‑care sector.

03

What to watch

Potential headwinds from Medicare/Medicaid policy changes and rising healthcare costs could temper upside

Relevance 9/10Novelty 9/10Timing: post-market today

Background

UnitedHealth Group is a diversified health‑care company with two main businesses, UnitedHealthcare and Optum, serving ~95 million members.

Company-level read

Ticker impact

$UNHBullishHigh confidence
Context

UnitedHealth Group reported Q3 2026 revenue of $113B, adjusted EPS $4.69 and reaffirmed full-year EPS guidance of at least $20.50.

Expected impact

likely upward pressure as investors price in solid earnings and guidance

Evidence & confidence

Quarterly results beat expectations and guidance remains robust, supporting a bullish bias.

Market effects

Sector

reinforces strength of the healthcare plans sector and may lift peers with similar government‑contract exposure

Regional

supports broader US market sentiment, especially defensive and dividend‑focused stocks

Global

adds to global healthcare sector confidence, but impact is primarily US‑centric

Counterpoint

What could challenge this read

Insider selling and guru trimming could signal caution despite strong numbers

Key entities

  • company
    UnitedHealth Group

    US‑listed health‑care giant (ticker UNH) reporting Q3 2026 results

Read at source← All news

StoryUnitedHealth posts $112.7 B Q3 revenue, $4.69 adjusted EPS and lifts FY‑2026 earnings outlook

Also covered by

5 outlets

Related articles

OCT 13
$UNHMedAI 9/10

UnitedHealth Group Inc (UNH) (Q3 2026) Earnings Call Highlights:

UnitedHealth Group (UNH) reported Q3 2026 revenue of $113 billion and adjusted EPS of $4.69, up from $2.92 a year ago. The company raised its full-year adjusted EPS guidance to at least $20.50. Key highlights include a 30% reduction in prior authorizations, AI-driven efficiencies, and Medicare Advantage margin expectations near the top of the 2% to 4% range. Challenges include elevated commercial medical trends and negative Medicaid margins.

gurufocus.com6 min
OCT 13
$UNHMedAI 8/10

UnitedHealth Raises Guidance: What It Means for Healthcare ETFs - UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH) raised its full-year 2026 adjusted earnings guidance to at least $20.50 per share, up from $19.50-$20.00, exceeding analyst estimates. The company's medical care ratio improved, but included one-time benefits. Revenue from UnitedHealthcare and Optum Health declined, while Optum Insight and Optum Rx saw growth. The update may impact healthcare ETFs with UNH exposure, such as XLV, IHF, and VHT.

benzinga.com5 min
OCT 13
$UNHMedAI 9/10

UnitedHealth reports $112.7B Q3 revenue and raises outlook

UnitedHealth Group (NYSE:UNH) reported Q3 2026 revenue of $112.7B, earnings of $4.56 per share, and raised its full-year earnings outlook to at least $20.50 per share. The company's operating cash flow was $5.1B, with a net margin of 3.6%. UnitedHealthcare and Optum reported revenues of $86.3B and $66.9B, respectively.

grafa.com3 min
OCT 13
$UNHMedAI 8/10

UnitedHealth Group stock trims gains on profit outlook increase

UnitedHealth Group (UNH) raised its full-year profit forecast to at least $20.50 per share, up from $19.50-$20, after Q3 earnings beat estimates. The stock initially jumped 5% but trimmed gains. The company is executing a turnaround plan. Year-to-date, the stock is up 14%. Berkshire Hathaway previously sold its stake in UNH.

finance.yahoo.com4 min
OCT 13
$UNHHighAI 9/10

UnitedHealth Stock Wobbles Despite 61% Profit Jump, Boosted Outlook - UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH) reported Q3 adjusted EPS of $4.69, up 61% YoY, and raised its 2026 adjusted EPS guidance to at least $20.50. Revenue was $112.69B, beating estimates. The company cited plan design and new pricing for improved medical care ratio. Management suggested 2027 consensus estimates may be too low. Shares initially rose 2% pre-market but reversed after the call.

benzinga.com6 min